This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.

Contact Us

What can we help you find?

Top Searches

PROTAC

ADC

RNA

ADME

OLIGO

In Vitro MetID (Metabolite Profiling and Identification)

In vitro metabolite profiling and identification (MetID), known for its simplicity, rapidity, and high throughput, is widely used in the pharmaceutical industry to investigate the biotransformation of test articles and predict the in vivo metabolism. It can provide the basis for the lead compound optimization, drug toxicological experiments, and metabolic enzyme phenotype study.

  • Overview

  • Assays

  • Case Study

  • Experience

  • Instruments and Software

  • FAQs

  • Related Resources

  • Related Services

Overview

MetID team utilizes ultra-high performance liquid chromatography (UPLC) coupled with a photodiode array detector (PDA) and high-resolution mass spectrometry (HRMS) to search for and identify the metabolites generated in incubation systems, which can provide three types of routine assays based on different purposes, including metabolic soft-spot analysis, reactive metabolite trapping and cross-species metabolism comparison. Meanwhile, the team can provide some special types of assays or methods, such as acidified S9/lysosomal systems used for antibody drug conjugates (ADCs), metabolite matching, hydrogen/deuterium (H/D) exchange and titanium trichloride reduction assays used to confirm the metabolite structure.

Learn More

Start your study

Case Study

  • Metabolite Profiling and Identification of Compound A (Commercially Available) in Rat, Dog, Monkey, and Human Hepatocytes

    A total of eight metabolites (M1-M8) were detected and identified by LC-UV-HRMS after incubated in rat, dog, monkey, and human hepatocytes for 120 minutes. The LC-UV (λ: 270-360 nm) chromatograms and the relative abundance of compound A and its metabolites were summarized in Figure 1 and Table 1, respectively.

    Compared with animal species, the metabolites formed in incubation of human hepatocytes were detected in hepatocytes of at least two animal species. In human hepatocytes, M1, M6 and M8 were considered to be the top three metabolites, while the relative abundance of M6 in all animal species was less than 1% which may due to further glucuronidation of M6. By comprehensive comparison with animal species, the metabolite profiling of compound A in human hepatocytes was similar to that in dog hepatocytes. Considering the similarity of metabolism in vitro, dog is a suitable large animal species for toxicological evaluation of compound A.

    Learn More

    • H02_图12.png

      Metabolite profiles (LC-UV) of Compound A in rat, dog, monkey, and human hepatocytes

      Figure 1

    • H02_图11.png

      The relative abundance of compound A and its metabolites in rat, dog, monkey, and human hepatocytes

      Table 1

Experience

  • 16+

    Years of experience

    E1icon06.svg
  • 500+

    Submissions of IND applications

    E1icon07.svg
  • 8000+

    Screening projects

    E1icon11.svg

Instruments and Software

  • Instruments

  • Software

    • E1_图1.png

      Thermo Orbitrap Eclipse™ Tribrid™

    • E1_图2.png

      Thermo Orbitrap Exploris™ 480

    • E1_图3.png

      Thermo Q-Exactive™ HF

    • E1_图4.png

      Waters VION™ IMS QTof

    • E1_图5.png

      Thermo Q-Exactive™ Plus

    • E1_图6.png

      Thermo Q-Exactive™

    • E1_图7.png

      Therno LTQ Orbitrap XL

    • E1_图8.png

      Waters Xevo®G2 QTof

    • E1_图9.png

      Solid scintillation counter: off-line detection of radioactivity

    • E1_图10.png

      Liquid scintillation counter: total radioactivity detection

    • E1_图11.png

      On-line detection of radioactivity

    • Thermo Scientific.png

      Thermo Scientific™ Compound Discoverer™

    • Mass Frontier.png

      Thermo Scientific™ Mass Frontier™

    • Metworks.png

      Thermo Scientific™ Metworks™

    • Waters MetaboLynx.png

      Waters MetaboLynxTM

    • Mass Analytical.png

      Mass Analytical Mass-MetaSite

    • UNIFI.png

      Waters UNIFI®

    • Biopharma.png

      Thermo Scientific™ Biopharma Finder™

FAQs

  • How is in vitro metabolite profiling and identification performed?

    Based on the purpose of the experiment, appropriate metabolic systems (liver microsomes, hepatocytes and plasma, etc.) and incubation conditions (incubation time, substrate concentration, enzyme concentration and so on) were selected for incubation. After incubation, samples would be extracted by suitable pre-treatment methods such as protein precipitation, liquid-liquid extraction, solid phase extraction and so on, then analyzed by LC-UV-HRMS.

    Metabolites will be screened by the comparison with the blank control samples, the structures of the metabolites and metabolic pathway would be proposed based on the interpretation of their MS and MS2 data and fragmentation pattern of test article, combined with diverse data processing software, multiple data processing techniques and professional judgment of the researchers.

  • What analytical techniques are used in in vitro metabolite profiling and identification?

    In vitro MetID utilizes ultra-high performance liquid chromatography (UPLC) coupled with a photodiode array detector (PDA) and high-resolution mass spectrometry (HRMS) for data acquisition, and combined with data processing software (Xcalibur, Compound Discoverer, Masslynx, Mass Metasite, etc.) and multiple data processing techniques (mass deficit filtering, background deduction, characteristic ion extraction, and isotope filtering, etc.) to search for and to identify metabolites.

  • When conducting an in vitro MetID study, how to determine incubation conditions such as incubation time and matrices?

    When conducting in vitro MetID study, the incubation time and incubation matrixes will be adjusted based on the purpose of the experiment and the in vitro stability of the test compound in the incubation medium. For example, when performing a metabolic soft spot analysis, long incubation time is not recommended, generally 1-2 half-life are suitable. When conducting in vitro MetID study of slow metabolic compounds in hepatocytes, adherent cells or relay method would be suitable for incubation.

  • Based on the results of in vitro MetID study, which metabolites should be focused on?

    Metabolites which are only found in human or have significantly higher proportion in human than other species or have potential toxicity (e.g. glucuronidation metabolites) require extra attention.

Stay Connected

Keep up with the latest news and insights.

  • Email address*

    * Please check the filled content
  • First name*

    * Please check the filled content
  • Last name*

    * Please check the filled content
  • Company*

    * Please check the filled content

By clicking submit, you consent to WuXi AppTec DMPK collecting and processing the information you provide for our internal purposes, in accordance with our privacy policy.

* Please agree to the Privacy Policy

Thanks for signing up

Help us get to know you better! By customizing your email preferences, we can deliver curated content relevant to you.